ONCAlert | 2017 San Antonio Breast Cancer Symposium

Treatments on the Horizon in NETs

Matthew Kulke, MD
Published Online:10:24 AM, Wed November 1, 2017

Matthew Kulke, MD, director, Neuroendocrine and Carcinoid Tumors Program, Dana-Farber Cancer Institute, discusses treatment options on the horizon in the treatment of neuroendocrine tumors (NETs) during the 2017 NANETS Symposium.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.